Literature DB >> 1745432

Animal test systems to study behavioral dysfunctions of neurodegenerative disorders.

W K Anger1.   

Abstract

The Eighth International Neurotoxicology Conference, Role of Toxicants in Neurological Disorders (1990), evaluated the evidence that chemical exposures may play a role in the development of neurodegenerative disorders. This article describes the major neurodegenerative disorders (Amyotrophic Lateral Sclerosis, Huntington disease, Parkinson disease, and Alzheimer disease) addressed at the conference, followed by a description of test systems or models developed to study behavioral aspects of these disorders in animals. However, due to the complexity of the disorders and the species in which they are found, fully-developed models in animals of neurodegenerative disorders are lacking. This suggests the need for a clear strategy for selecting behavioral tests in animals to study aspects of any neurodegenerative disorders. Such a strategy is here exemplified for Alzheimer disease (AD) as a prototypical neurodegenerative disorder. Since an animal model cannot provide the full range of effects of human neurodegenerative diseases, particularly AD which produces incompletely characterized cognitive deficits, a rodent model must at this time be drawn from multiple sources, including: (1) Tests currently used to identify in rodents deficits associated with AD; (2) tests to identify Alzheimer-related signs in patients; and, (3) tests that relate to theoretical constructs of human and animal cognition. A battery that draws from those sources could include tests of: (a) Spatial learning and memory (Morris Water Maze and Radial Arm Maze), (b) delayed recall match-to-sample; (c) serial response learning; and, (d) visual discrimination (e.g., vertical vs. horizontal stimuli). This battery will identify behavioral changes characteristic of early-, middle- and late-stage AD, afford the potential to relate the findings to theoretical constructs of cognition, and evaluate learning capabilities not previously studied in rodent models of neurodegenerative disorders.

Entities:  

Mesh:

Year:  1991        PMID: 1745432

Source DB:  PubMed          Journal:  Neurotoxicology        ISSN: 0161-813X            Impact factor:   4.294


  5 in total

1.  Reduced glutamate neurotransmission in patients with Alzheimer's disease -- an in vivo (13)C magnetic resonance spectroscopy study.

Authors:  Alexander P Lin; Frederick Shic; Cathleen Enriquez; Brian D Ross
Journal:  MAGMA       Date:  2003-02       Impact factor: 2.310

2.  Predictors of virtual radial arm maze performance in adolescent Italian children.

Authors:  Joe M Braun; Roberto Lucchini; David C Bellinger; Elaine Hoffman; Marco Nazzaro; Donald R Smith; Robert O Wright
Journal:  Neurotoxicology       Date:  2012-07-06       Impact factor: 4.294

3.  Opioid receptor-mediated control of acetylcholine release in human neocortex tissue.

Authors:  T J Feuerstein; O Gleichauf; D Peckys; G B Landwehrmeyer; R Scheremet; R Jackisch
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1996-11       Impact factor: 3.000

4.  Flumazenil and tacrine increase the effectiveness of ondansetron on scopolamine-induced impairment of spatial learning in rats.

Authors:  M Diez-Ariza; C Redondo; M García-Alloza; B Lasheras; J Del Río; M J Ramírez
Journal:  Psychopharmacology (Berl)       Date:  2003-07-04       Impact factor: 4.530

5.  Antioxidant capacity in rat brain after intracerebroventricular treatment with streptozotocin and alloxan--a preliminary study.

Authors:  A Sapcanin; E Sofic; I Tahirovic; M Salkovic-Petrisic; S Hoyer; P Riederer
Journal:  Neurotox Res       Date:  2008-04       Impact factor: 3.978

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.